Jean Claude Bassila, MD
Nephrology · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Offices
- 5
- Since medical school
- 20 years
- Graduated 2006
Offices
5 locations · Telemedicine Group PC · Barton Medical Foundation · East Bay Nephrology Medical Group Inc · Siskiyou Hospital Inc
Looking this up.
Hospitals listed: 052524 · Mayers Memorial Hospital · Novato Community Hospital · Petaluma Valley Hospital · Providence Santa Rosa Memorial Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bassila’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A145965 · Current
Licensed to practise in California · since 2016 · expires 2026-11-30 · American University of Beirut Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mayers Memorial HospitalFall River Mills, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency department74% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Petaluma Valley HospitalPetaluma, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Mayers Memorial Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 64 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5 · 60 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 45 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 85% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| "Always" quiet at night | 64% |
| "YES", patients would definitely recommend the hospital | 74% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Petaluma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.31 (0.23 to 2.39) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 533 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,427 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.65) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.61 (0 to 18.36) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (0.85 to 9.47) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.41) · 1,184 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.1 · 26 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.308 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3 · 143 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 17.8) · 364 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 138 cases | No different | Jan 2024 – Dec 2024 |
What patients said (246 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$323,180
Medicare paid this office $323,180 for 325 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 30 | $65,958 | $289 |
| Return visit (30+ min) | 180 | $37,714 | $97 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 55 | $36,147 | $41 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 57 | $35,465 | $34 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 55 | $24,421 | $52 |
See all 19 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 30 | $65,958 | $289 |
| Return visit (30+ min) | 180 | $37,714 | $97 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 55 | $36,147 | $41 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 57 | $35,465 | $34 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 55 | $24,421 | $52 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 64 | $21,771 | $42 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 57 | $21,682 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $17,826 | $97 |
| New patient visit (45+ min) | 101 | $12,482 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $8,926 | $142 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $7,563 | $244 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $6,138 | $65 |
| Long return visit (40+ min) | 29 | $5,763 | $141 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 181 | $5,393 | $13 |
| New patient visit (60+ min) | 22 | $3,383 | $154 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $2,658 | $111 |
| Short return visit (20+ min) | 29 | $2,121 | $71 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $847 | $8 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 14 | $246 | $18 |
Who their Medicare patients are
325 Original Medicare patients in 2024. Average age 76 · Under 65 9% · 85 and older 16% · Women 50% · Also on Medicaid 35% · Health risk score 2.98. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 55% · Coronary heart disease 40% · Heart failure 40% · Atrial fibrillation 33% · Depression 28% · COPD 23% · Cancer 18% · Stroke 9% · Dementia 8%.
The office billed $872,285, Medicare allowed $416,958 and paid $323,180; for 5,200 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 325 | 5,200 | 76 | 2.98 | $872,285 | $323,180 |
| 2023 | 296 | 3,731 | 74 | 3.92 | $745,046 | $279,427 |
| 2022 | 238 | 1,410 | 74 | 4.29 | $522,856 | $200,683 |
| 2021 | 195 | 1,261 | 74 | 4.29 | $500,365 | $199,779 |
| 2020 | 410 | 2,455 | 75 | 3.65 | $798,643 | $261,463 |
| 2019 | 441 | 3,059 | 74 | 4.14 | $863,507 | $267,435 |
| 2018 | 643 | 3,410 | 69 | 5.14 | $1,013,688 | $281,646 |
| 2017 | 571 | 7,937 | 67 | 4.75 | $1,365,668 | $370,555 |
| 2016 | 564 | 5,397 | 68 | 4.26 | $1,152,565 | $340,624 |
| 2015 | 374 | 4,758 | 67 | 4.73 | $956,915 | $276,707 |
| 2014 | 343 | 4,311 | 66 | 3.93 | $470,450 | $145,722 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 31 | $67,018 | $293 |
| Return visit (30+ min) | 141 | $34,718 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $25,278 | $99 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 61 | $22,763 | $41 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 64 | $20,785 | $53 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 47 | $16,344 | $34 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 66 | $15,116 | $43 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 47 | $13,410 | $47 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $12,615 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $11,249 | $65 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 16 | $10,119 | $247 |
| New patient visit (45+ min) | 63 | $7,407 | $118 |
| Hemodialysis procedure with physician evaluation | 27 | $5,154 | $59 |
| Long return visit (40+ min) | 19 | $2,778 | $111 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,465 | $103 |
| New patient visit (60+ min) | 15 | $2,180 | $145 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,728 | $108 |
| Dialysis services, per day, less than full month service (20 years or older) | 24 | $1,135 | $7 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 47 | $829 | $18 |
2022: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 38 | $99,929 | $306 |
| Return visit (30+ min) | 118 | $36,590 | $104 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 25 | $13,081 | $247 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $10,122 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $9,273 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $8,303 | $86 |
| Hemodialysis procedure with physician evaluation | 27 | $6,744 | $62 |
| New patient visit (45+ min) | 38 | $4,603 | $121 |
| Long return visit (40+ min) | 21 | $3,197 | $133 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,596 | $73 |
| Dialysis services, per day, less than full month service (20 years or older) | 15 | $951 | $8 |
2021: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 46 | $108,567 | $308 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $23,340 | $256 |
| Return visit (30+ min) | 91 | $18,426 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $12,960 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $8,697 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $7,976 | $170 |
| New patient visit (45+ min) | 37 | $5,415 | $146 |
| Hemodialysis procedure with physician evaluation | 25 | $4,713 | $62 |
| Dialysis services, per day, less than full month service (20 years or older) | 12 | $859 | $8 |
2020: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 46 | $60,254 | $239 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 52 | $44,794 | $201 |
| Return visit (30+ min) | 183 | $36,471 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $25,719 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $23,821 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $21,049 | $170 |
| Short return visit (20+ min) | 159 | $13,225 | $61 |
| Hemodialysis procedure with physician evaluation | 35 | $6,165 | $62 |
| New patient visit (45+ min) | 43 | $5,931 | $138 |
| Telephone medical discussion with physician, 11-20 minutes | 61 | $4,954 | $65 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $4,025 | $155 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,490 | $116 |
| New patient visit (30+ min) | 28 | $2,514 | $90 |
| Dialysis services, per day, less than full month service (20 years or older) | 17 | $948 | $7 |
| Telephone medical discussion with physician, 5-10 minutes | 20 | $814 | $39 |
2019: 13 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 63 | $72,104 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 105 | $34,028 | $57 |
| Return visit (30+ min) | 189 | $32,866 | $83 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 45 | $28,657 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $25,990 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $20,316 | $164 |
| Short return visit (20+ min) | 204 | $17,272 | $57 |
| Hemodialysis procedure with physician evaluation | 40 | $9,622 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 60 | $8,041 | $101 |
| Dialysis services, 1 physician visit per month (20 years or older) | 28 | $6,642 | $141 |
| New patient visit (45+ min) | 37 | $4,809 | $130 |
| Dialysis services, per day, less than full month service (20 years or older) | 45 | $2,836 | $6 |
| New patient visit (30+ min) | 21 | $1,719 | $82 |
2018: 14 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 182 | $82,931 | $176 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 146 | $70,117 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 160 | $36,778 | $55 |
| Return visit (30+ min) | 172 | $17,989 | $74 |
| Dialysis services, 1 physician visit per month (20 years or older) | 68 | $16,675 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 97 | $12,045 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $10,551 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,148 | $151 |
| Short return visit (20+ min) | 125 | $6,993 | $54 |
| Hemodialysis procedure with physician evaluation | 59 | $5,831 | $55 |
| New patient visit (45+ min) | 18 | $2,101 | $117 |
| Dialysis services, per day, less than full month service (20 years or older) | 28 | $1,205 | $6 |
| New patient visit (30+ min) | 14 | $994 | $71 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $522 | $31 |
2017: 21 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 132 | $115,752 | $204 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 143 | $96,124 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $37,217 | $53 |
| Return visit (30+ min) | 186 | $20,752 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 122 | $16,787 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $12,302 | $76 |
| Dialysis services, 1 physician visit per month (20 years or older) | 45 | $11,940 | $133 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 23 | $10,665 | None |
| Home dialysis services per month (20 years or older) | 11 | $9,938 | $171 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,593 | $148 |
| Dialysis services, per day, less than full month service (20 years or older) | 74 | $7,547 | $6 |
| Hemodialysis procedure with physician evaluation | 65 | $5,977 | $53 |
| New patient visit (45+ min) | 47 | $4,997 | $106 |
| Short return visit (20+ min) | 68 | $2,885 | $40 |
| Dialysis procedure including 1 evaluation | 13 | $1,566 | $63 |
| Hemodialysis procedure requiring repeated evaluation | 12 | $1,228 | $77 |
| New patient visit (30+ min) | 14 | $889 | $64 |
| Injection of drug or substance under skin or into muscle | 23 | $745 | $17 |
| Hospital discharge day management, 30 minutes or less | 11 | $582 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $545 | $29 |
| Insertion of needle into vein for collection of blood sample | 18 | $71 | $3 |
2016: 21 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 112 | $130,646 | $203 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 111 | $52,746 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 180 | $34,756 | $53 |
| Return visit (30+ min) | 209 | $30,367 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $13,023 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $12,445 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 86 | $12,107 | $100 |
| Dialysis services, 1 physician visit per month (20 years or older) | 32 | $8,407 | $129 |
| Home dialysis services per month (20 years or older) | 11 | $7,874 | $171 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 13 | $7,145 | None |
| Hemodialysis procedure with physician evaluation | 71 | $6,659 | $54 |
| New patient visit (45+ min) | 45 | $4,624 | $103 |
| Long return visit (40+ min) | 34 | $4,239 | $87 |
| New patient visit (60+ min) | 30 | $3,913 | $130 |
| Short return visit (20+ min) | 76 | $3,687 | $44 |
| Hemodialysis procedure requiring repeated evaluation | 12 | $1,077 | $77 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,002 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $605 | $29 |
| Injection of drug or substance under skin or into muscle | 12 | $558 | $17 |
| New patient visit (30+ min) | 12 | $537 | $45 |
| Insertion of needle into vein for collection of blood sample | 51 | $241 | $3 |
2015: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 77 | $112,306 | $211 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 73 | $43,411 | $177 |
| Return visit (30+ min) | 129 | $23,120 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 138 | $22,619 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 80 | $11,822 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,654 | $152 |
| Hemodialysis procedure with physician evaluation | 61 | $8,497 | $55 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17 | $7,446 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $7,417 | $78 |
| Dialysis services, 1 physician visit per month (20 years or older) | 22 | $4,651 | $137 |
| Short return visit (20+ min) | 58 | $3,276 | $46 |
| New patient visit (60+ min) | 20 | $3,035 | $152 |
| Long return visit (40+ min) | 20 | $2,869 | $102 |
| New patient visit (45+ min) | 27 | $2,557 | $95 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $1,199 | $29 |
| Injection of drug or substance under skin or into muscle | 20 | $882 | $16 |
| Insertion of needle into vein for collection of blood sample | 65 | $323 | $3 |
2014: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 65 | $44,833 | $212 |
| Return visit (30+ min) | 117 | $16,795 | $75 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 49 | $15,006 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 99 | $13,434 | $54 |
| Dialysis services, 1 physician visit per month (20 years or older) | 50 | $7,637 | $136 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12 | $7,534 | None |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 59 | $6,892 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,524 | $152 |
| New patient visit (45+ min) | 47 | $5,518 | $117 |
| Short return visit (20+ min) | 75 | $5,147 | $49 |
| Hemodialysis procedure with physician evaluation | 32 | $3,577 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $2,720 | $78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 42 | $1,849 | $29 |
| Long return visit (40+ min) | 13 | $1,579 | $105 |
| New patient visit (60+ min) | 11 | $1,570 | $143 |
| Insertion of needle into vein for collection of blood sample | 160 | $953 | $3 |
| Injection of drug or substance under skin or into muscle | 12 | $634 | $17 |
Medicaid work
$22,147 in 2020
Medicaid paid $22,147 for 355 billed services this clinician did in 2020, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 123 | $13,276 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 77 | $5,946 |
| Return visit (30+ min) | 155 | $2,925 |
| 2020 | 355 | 3 | 24 | $22,147 |
| 2019 | 126 | 3 | 21 | $4,585 |
| 2018 | 780 | 5 | 87 | $21,846 |
See the largest Medicaid services in earlier years
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 41 | $3,147 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 66 | $1,168 |
| Return visit (30+ min) | 19 | $270 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 209 | $9,270 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 273 | $7,530 |
| Return visit (30+ min) | 55 | $2,282 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 80 | $1,438 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 163 | $1,326 |
Drugs they prescribed that Part D paid
$188,888
Pharmacies billed $188,888 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
668 generic and 106 brand-name prescriptions · $188,888 in drug cost · 23 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 11 | $34,372 | $3,125 |
| Veltassa | 29 | $33,781 | $1,165 |
| Jardiance | 16 | $27,271 | $1,704 |
| Sevelamer Carbonate | 27 | $19,459 | $721 |
| Kerendia | 15 | $18,026 | $1,202 |
See all 22 drugs
| Velphoro | 11 | $34,372 | $3,125 |
| Veltassa | 29 | $33,781 | $1,165 |
| Jardiance | 16 | $27,271 | $1,704 |
| Sevelamer Carbonate | 27 | $19,459 | $721 |
| Kerendia | 15 | $18,026 | $1,202 |
| Lanthanum Carbonate | 15 | $11,659 | $777 |
| Lokelma | 11 | $8,077 | $734 |
| Cinacalcet | 11 | $5,529 | $503 |
| Calcitriol | 38 | $920 | $24 |
| Albuterol Sulfate Hfa | 11 | $841 | $76 |
| Tamsulosin | 34 | $637 | $19 |
| Furosemide | 79 | $581 | $7 |
| Amlodipine Besylate | 67 | $435 | $6 |
| Atorvastatin | 44 | $421 | $10 |
| Losartan | 29 | $394 | $14 |
| Allopurinol | 35 | $294 | $8 |
| Potassium Chloride | 21 | $289 | $14 |
| Chlorthalidone | 16 | $282 | $18 |
| Lisinopril | 14 | $103 | $7 |
| Hydrochlorothiazide | 15 | $98 | $7 |
| Gabapentin | 11 | $95 | $9 |
| Carvedilol | 12 | $71 | $6 |
Year by year
| 2024 | 774 | 151 | None | 14% | $188,888 |
| 2023 | 771 | 121 | 0% (0) | 17% | $221,442 |
| 2022 | 698 | 113 | 0% (0) | None | $280,944 |
| 2021 | 640 | 145 | None | None | $242,877 |
| 2020 | 1,262 | 207 | None | 18% | $261,552 |
| 2019 | 1,459 | 257 | None | 19% | $424,017 |
| 2018 | 2,878 | 341 | 2% (50) | None | $1,337,610 |
| 2017 | 4,141 | 306 | 2% (86) | None | $2,378,365 |
| 2016 | 3,887 | 270 | 3% (117) | None | $1,871,633 |
| 2015 | 2,937 | 210 | 5% (133) | 37% | $1,156,977 |
| 2014 | 2,090 | 173 | 5% (113) | None | $555,511 |
| 2013 | 28 | 21 | None | None | $688 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Veltassa | 27 | $36,971 | $1,369 |
| Sevelamer Carbonate | 25 | $28,278 | $1,131 |
| Lokelma | 21 | $22,312 | $1,062 |
| Cinacalcet | 11 | $18,248 | $1,659 |
| Jardiance | 12 | $17,597 | $1,466 |
| Farxiga | 11 | $6,983 | $635 |
| Potassium Citrate Er | 12 | $1,887 | $157 |
| Amlodipine Besylate | 86 | $1,309 | $15 |
| Allopurinol | 39 | $827 | $21 |
| Calcitriol | 41 | $789 | $19 |
| Losartan | 38 | $777 | $20 |
| Furosemide | 86 | $766 | $9 |
| Atorvastatin | 26 | $464 | $18 |
| Chlorthalidone | 18 | $309 | $17 |
| Carvedilol | 14 | $287 | $20 |
| Benazepril | 11 | $285 | $26 |
| Potassium Chloride | 14 | $270 | $19 |
| Tamsulosin | 21 | $203 | $10 |
| Gabapentin | 13 | $112 | $9 |
| Hydrochlorothiazide | 16 | $63 | $4 |
2022: 17 drugs
| Renvela | 23 | $57,257 | $2,489 |
| Veltassa | 21 | $41,516 | $1,977 |
| Sevelamer Carbonate | 33 | $35,654 | $1,080 |
| Cinacalcet | 12 | $34,551 | $2,879 |
| Lokelma | 15 | $15,035 | $1,002 |
| Calcitriol | 52 | $1,118 | $22 |
| Amlodipine Besylate | 61 | $848 | $14 |
| Allopurinol | 35 | $767 | $22 |
| Losartan | 25 | $479 | $19 |
| Chlorthalidone | 12 | $451 | $38 |
| Hydralazine | 17 | $407 | $24 |
| Furosemide | 42 | $402 | $10 |
| Carvedilol | 18 | $307 | $17 |
| Potassium Chloride | 12 | $228 | $19 |
| Alprazolam | 21 | $94 | $4 |
| Lisinopril | 14 | $77 | $6 |
| Prednisone | 12 | $60 | $5 |
2021: 13 drugs
| Renvela | 28 | $94,881 | $3,389 |
| Veltassa | 18 | $25,746 | $1,430 |
| Cinacalcet | 13 | $20,382 | $1,568 |
| Sevelamer Carbonate | 49 | $20,043 | $409 |
| Calcitriol | 55 | $1,493 | $27 |
| Allopurinol | 41 | $1,018 | $25 |
| Amlodipine Besylate | 59 | $625 | $11 |
| Tamsulosin | 21 | $600 | $29 |
| Furosemide | 39 | $592 | $15 |
| Losartan | 20 | $366 | $18 |
| Carvedilol | 13 | $241 | $19 |
| Alprazolam | 16 | $94 | $6 |
| Lisinopril | 12 | $89 | $7 |
2020: 25 drugs
| Renvela | 47 | $76,455 | $1,627 |
| Velphoro | 15 | $74,461 | $4,964 |
| Sevelamer Carbonate | 83 | $28,775 | $347 |
| Veltassa | 29 | $26,398 | $910 |
| Cinacalcet | 11 | $6,470 | $588 |
| Bumetanide | 38 | $5,181 | $136 |
| Calcitriol | 98 | $3,271 | $33 |
| Tamsulosin | 68 | $1,572 | $23 |
| Amlodipine Besylate | 127 | $1,372 | $11 |
| Allopurinol | 67 | $1,256 | $19 |
| Nifedipine Er | 11 | $914 | $83 |
| Calcium Acetate | 17 | $902 | $53 |
| Furosemide | 89 | $805 | $9 |
| Carvedilol | 36 | $695 | $19 |
| Losartan | 38 | $612 | $16 |
| Potassium Chloride | 29 | $602 | $21 |
| Diltiazem 24hr Er (Cd) | 14 | $583 | $42 |
| Ultra-Fine Short Pen Needle | 11 | $519 | $47 |
| Hydralazine | 23 | $429 | $19 |
| Spironolactone | 33 | $408 | $12 |
| Atorvastatin | 37 | $311 | $8 |
| Lisinopril | 47 | $279 | $6 |
| Benazepril | 13 | $192 | $15 |
| Atenolol | 12 | $154 | $13 |
| Alprazolam | 15 | $103 | $7 |
2019: 32 drugs
| Renvela | 77 | $158,294 | $2,056 |
| Sevelamer Carbonate | 106 | $82,071 | $774 |
| Velphoro | 28 | $71,129 | $2,540 |
| Auryxia | 34 | $33,590 | $988 |
| Lanthanum Carbonate | 23 | $24,044 | $1,045 |
| Veltassa | 12 | $7,784 | $649 |
| Bumetanide | 38 | $4,608 | $121 |
| Potassium Citrate Er | 14 | $2,562 | $183 |
| Calcitriol | 85 | $2,251 | $26 |
| Calcium Acetate | 22 | $1,623 | $74 |
| Allopurinol | 62 | $1,508 | $24 |
| Tamsulosin | 61 | $1,345 | $22 |
| Amlodipine Besylate | 117 | $1,273 | $11 |
| Nifedipine Er | 15 | $1,148 | $77 |
| Losartan | 57 | $1,085 | $19 |
| Olmesartan Medoxomil | 15 | $967 | $64 |
| Furosemide | 105 | $811 | $8 |
| Potassium Chloride | 25 | $686 | $27 |
| Hydralazine | 25 | $649 | $26 |
| Diltiazem 24hr Er (Cd) | 12 | $604 | $50 |
| Metoprolol | 29 | $602 | $21 |
| Carvedilol | 43 | $467 | $11 |
| Spironolactone | 34 | $428 | $13 |
| Lisinopril | 48 | $386 | $8 |
| Atenolol | 14 | $175 | $13 |
| Benazepril | 16 | $158 | $10 |
| Clonidine | 13 | $154 | $12 |
| Atorvastatin | 17 | $147 | $9 |
| Cephalexin | 20 | $135 | $7 |
| Ciprofloxacin | 17 | $132 | $8 |
| Hydrochlorothiazide | 17 | $114 | $7 |
| Simvastatin | 13 | $100 | $8 |
2018: 48 drugs
| Renvela | 271 | $551,879 | $2,036 |
| Sevelamer Carbonate | 232 | $370,787 | $1,598 |
| Auryxia | 140 | $195,270 | $1,395 |
| Velphoro | 51 | $69,761 | $1,368 |
| Renagel | 18 | $61,281 | $3,405 |
| Veltassa | 11 | $9,213 | $838 |
| Tacrolimus | 11 | $5,988 | $544 |
| Calcium Acetate | 16 | $3,965 | $248 |
| Clonidine | 16 | $2,673 | $167 |
| Calcitriol | 96 | $1,895 | $20 |
| Novolin 70-30 | 12 | $1,688 | $141 |
| Hydralazine | 105 | $1,678 | $16 |
| Metolazone | 23 | $1,394 | $61 |
| Furosemide | 244 | $1,267 | $5 |
| Voltaren | 11 | $1,042 | $95 |
| Nifedipine Er | 28 | $1,042 | $37 |
| Doxazosin Mesylate | 40 | $1,013 | $25 |
| Amlodipine Besylate | 251 | $875 | $3 |
| Losartan | 90 | $847 | $9 |
| Allopurinol | 63 | $777 | $12 |
| Ventolin Hfa | 13 | $735 | $57 |
| Labetalol | 16 | $709 | $44 |
| Lidocaine-Prilocaine | 19 | $557 | $29 |
| Hydrocodone-Acetaminophen | 43 | $543 | $13 |
| Gabapentin | 51 | $540 | $11 |
| Atorvastatin | 73 | $533 | $7 |
| Potassium Chloride | 41 | $513 | $13 |
| Metoprolol | 44 | $479 | $11 |
| Carvedilol | 90 | $453 | $5 |
| Tamsulosin | 23 | $451 | $20 |
| Clonidine | 51 | $416 | $8 |
| Valsartan | 18 | $393 | $22 |
| Spironolactone | 31 | $239 | $8 |
| Omeprazole | 24 | $227 | $9 |
| Lisinopril | 42 | $214 | $5 |
| Cyclobenzaprine | 21 | $207 | $10 |
| Ondansetron | 12 | $185 | $15 |
| Pantoprazole | 28 | $181 | $6 |
| Atenolol | 27 | $181 | $7 |
| Famotidine | 11 | $147 | $13 |
| Zolpidem | 20 | $143 | $7 |
| Isosorbide Mononitrate Er | 12 | $120 | $10 |
| Benazepril | 15 | $95 | $6 |
| Metoprolol | 22 | $92 | $4 |
| Prednisone | 14 | $92 | $7 |
| Clopidogrel | 18 | $60 | $3 |
| Terazosin | 12 | $49 | $4 |
| Temazepam | 11 | $39 | $4 |
2017: 53 drugs
| Renvela | 525 | $1,228,117 | $2,339 |
| Sensipar | 482 | $808,055 | $1,676 |
| Auryxia | 123 | $135,020 | $1,098 |
| Velphoro | 53 | $63,466 | $1,197 |
| Sevelamer Carbonate | 18 | $33,305 | $1,850 |
| Fosrenol | 17 | $19,653 | $1,156 |
| Veltassa | 13 | $11,462 | $882 |
| Lialda | 12 | $6,419 | $535 |
| Calcium Acetate | 54 | $5,964 | $110 |
| Calcitriol | 141 | $3,141 | $22 |
| Nifedipine Er | 64 | $2,572 | $40 |
| Hydralazine | 161 | $1,932 | $12 |
| Metolazone | 30 | $1,865 | $62 |
| Lidocaine-Prilocaine | 30 | $1,389 | $46 |
| Doxazosin Mesylate | 60 | $1,348 | $22 |
| Furosemide | 308 | $1,195 | $4 |
| Hydrocodone-Acetaminophen | 80 | $1,041 | $13 |
| Amlodipine Besylate | 305 | $973 | $3 |
| Voltaren | 12 | $945 | $79 |
| Allopurinol | 60 | $780 | $13 |
| Atorvastatin | 88 | $696 | $8 |
| Losartan | 137 | $611 | $4 |
| Rosuvastatin | 13 | $592 | $46 |
| Clonidine | 82 | $577 | $7 |
| Megestrol Acetate | 25 | $561 | $22 |
| Metoprolol | 36 | $525 | $15 |
| Pravastatin | 40 | $493 | $12 |
| Potassium Chloride | 39 | $434 | $11 |
| Carvedilol | 113 | $426 | $4 |
| Polyethylene Glycol 3350 | 20 | $278 | $14 |
| Omeprazole | 50 | $269 | $5 |
| Ondansetron | 14 | $263 | $19 |
| Minoxidil | 18 | $253 | $14 |
| Gabapentin | 56 | $240 | $4 |
| Lisinopril | 59 | $216 | $4 |
| Lactulose | 29 | $207 | $7 |
| Isosorbide Mononitrate Er | 22 | $206 | $9 |
| Zolpidem | 31 | $195 | $6 |
| Promethazine | 18 | $187 | $10 |
| Pantoprazole | 20 | $177 | $9 |
| Spironolactone | 30 | $174 | $6 |
| Atenolol | 40 | $133 | $3 |
| Ranitidine | 21 | $126 | $6 |
| Clopidogrel | 12 | $120 | $10 |
| Hydrochlorothiazide | 21 | $115 | $5 |
| Cyclobenzaprine | 23 | $115 | $5 |
| Metoprolol | 28 | $114 | $4 |
| Cilostazol | 14 | $109 | $8 |
| Amiodarone | 16 | $104 | $7 |
| Pioglitazone | 12 | $87 | $7 |
| Simvastatin | 18 | $66 | $4 |
| Lovastatin | 12 | $52 | $4 |
| Alprazolam | 12 | $19 | $2 |
2016: 61 drugs
| Renvela | 465 | $1,038,185 | $2,233 |
| Sensipar | 365 | $550,750 | $1,509 |
| Velphoro | 104 | $113,238 | $1,089 |
| Fosrenol | 38 | $45,033 | $1,185 |
| Renagel | 12 | $35,908 | $2,992 |
| Crestor | 23 | $5,799 | $252 |
| Calcitriol | 226 | $4,783 | $21 |
| Clonidine | 15 | $4,311 | $287 |
| Nexium | 11 | $4,241 | $386 |
| Paricalcitol | 14 | $3,340 | $239 |
| Lidocaine-Prilocaine | 41 | $2,996 | $73 |
| Potassium Chloride | 34 | $2,840 | $84 |
| Calcium Acetate | 21 | $2,760 | $131 |
| Metolazone | 27 | $1,653 | $61 |
| Hydralazine | 147 | $1,638 | $11 |
| Oxycodone-Acetaminophen | 52 | $1,388 | $27 |
| Furosemide | 327 | $1,092 | $3 |
| Doxazosin Mesylate | 42 | $922 | $22 |
| Hydrocodone-Acetaminophen | 42 | $850 | $20 |
| Nifedipine Er | 32 | $804 | $25 |
| Amlodipine Besylate | 244 | $736 | $3 |
| Pravastatin | 44 | $636 | $14 |
| Allopurinol | 57 | $620 | $11 |
| Atorvastatin | 67 | $523 | $8 |
| Omeprazole | 55 | $474 | $9 |
| Chlorthalidone | 16 | $432 | $27 |
| Losartan | 103 | $424 | $4 |
| Clonidine | 59 | $414 | $7 |
| Minoxidil | 32 | $359 | $11 |
| Megestrol Acetate | 18 | $355 | $20 |
| Valsartan | 16 | $317 | $20 |
| Lactulose | 36 | $284 | $8 |
| Clopidogrel | 22 | $264 | $12 |
| Gabapentin | 55 | $258 | $5 |
| Labetalol | 13 | $248 | $19 |
| Levothyroxine | 20 | $248 | $12 |
| Spironolactone | 38 | $242 | $6 |
| Metoprolol | 44 | $239 | $5 |
| Carvedilol | 70 | $224 | $3 |
| Lisinopril | 49 | $193 | $4 |
| Polyethylene Glycol 3350 | 11 | $173 | $16 |
| Pantoprazole | 27 | $168 | $6 |
| Lovastatin | 19 | $151 | $8 |
| Ranitidine | 33 | $150 | $5 |
| Zolpidem | 34 | $142 | $4 |
| Atenolol | 39 | $142 | $4 |
| Isosorbide Mononitrate Er | 15 | $136 | $9 |
| Glipizide | 33 | $124 | $4 |
| Ciprofloxacin | 24 | $120 | $5 |
| Promethazine | 19 | $120 | $6 |
| Azithromycin | 13 | $106 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $89 | $8 |
| Famotidine | 13 | $88 | $7 |
| Amiodarone | 15 | $85 | $6 |
| Pioglitazone | 12 | $83 | $7 |
| Tramadol | 21 | $66 | $3 |
| Cyclobenzaprine | 16 | $63 | $4 |
| Hydrochlorothiazide | 11 | $61 | $6 |
| Simvastatin | 18 | $60 | $3 |
| Citalopram Hbr | 11 | $18 | $2 |
| Alprazolam | 13 | $17 | $1 |
2015: 49 drugs
| Renvela | 344 | $654,416 | $1,902 |
| Sensipar | 218 | $348,522 | $1,599 |
| Velphoro | 78 | $68,420 | $877 |
| Fosrenol | 21 | $18,690 | $890 |
| Paricalcitol | 27 | $8,781 | $325 |
| Calcitriol | 273 | $5,931 | $22 |
| Nexium | 12 | $3,721 | $310 |
| Lidocaine-Prilocaine | 72 | $3,678 | $51 |
| Oxycodone-Acetaminophen | 78 | $2,512 | $32 |
| Metolazone | 29 | $1,941 | $67 |
| Hydralazine | 98 | $1,511 | $15 |
| Furosemide | 279 | $1,293 | $5 |
| Potassium Chloride | 35 | $1,133 | $32 |
| Nifedipine Er | 30 | $1,003 | $33 |
| Amlodipine Besylate | 205 | $685 | $3 |
| Pioglitazone | 12 | $510 | $43 |
| Allopurinol | 79 | $493 | $6 |
| Hydrocortisone | 13 | $449 | $35 |
| Atorvastatin | 36 | $422 | $12 |
| Losartan | 63 | $391 | $6 |
| Diphenoxylate-Atropine | 14 | $381 | $27 |
| Doxazosin Mesylate | 16 | $352 | $22 |
| Omeprazole | 35 | $346 | $10 |
| Zolpidem | 32 | $306 | $10 |
| Clopidogrel | 19 | $269 | $14 |
| Polyethylene Glycol 3350 | 18 | $256 | $14 |
| Clonidine | 28 | $221 | $8 |
| Hydrocodone-Acetaminophen | 16 | $214 | $13 |
| Carvedilol | 38 | $204 | $5 |
| Isosorbide Mononitrate Er | 17 | $201 | $12 |
| Enalapril Maleate | 15 | $195 | $13 |
| Lactulose | 26 | $189 | $7 |
| Lisinopril | 47 | $187 | $4 |
| Minoxidil | 20 | $184 | $9 |
| Metoprolol | 32 | $182 | $6 |
| Spironolactone | 17 | $178 | $10 |
| Lovastatin | 12 | $161 | $13 |
| Cyclobenzaprine | 15 | $158 | $11 |
| Gabapentin | 27 | $147 | $5 |
| Ondansetron | 13 | $129 | $10 |
| Terazosin | 12 | $125 | $10 |
| Atenolol | 24 | $124 | $5 |
| Tramadol | 38 | $109 | $3 |
| Promethazine | 16 | $107 | $7 |
| Amiodarone | 14 | $106 | $8 |
| Hydrochlorothiazide | 17 | $97 | $6 |
| Pantoprazole | 11 | $84 | $8 |
| Azithromycin | 15 | $83 | $6 |
| Simvastatin | 16 | $71 | $4 |
2014: 40 drugs
| Renvela | 173 | $319,092 | $1,844 |
| Sensipar | 130 | $162,361 | $1,249 |
| Velphoro | 14 | $12,172 | $869 |
| Paricalcitol | 33 | $10,787 | $327 |
| Calcium Acetate | 32 | $5,594 | $175 |
| Zemplar | 14 | $5,332 | $381 |
| Nexium | 14 | $4,503 | $322 |
| Furosemide | 267 | $1,382 | $5 |
| Losartan | 76 | $1,334 | $18 |
| Metolazone | 31 | $1,164 | $38 |
| Calcitriol | 48 | $1,044 | $22 |
| Hydralazine | 62 | $1,004 | $16 |
| Lidocaine-Prilocaine | 40 | $1,000 | $25 |
| Potassium Chloride | 25 | $986 | $39 |
| Amlodipine Besylate | 157 | $983 | $6 |
| Amlodipine Besylate-Benazepril | 11 | $713 | $65 |
| Omeprazole | 52 | $506 | $10 |
| Atorvastatin | 18 | $489 | $27 |
| Hydrocodone-Acetaminophen | 37 | $475 | $13 |
| Clopidogrel | 20 | $436 | $22 |
| Enalapril Maleate | 32 | $420 | $13 |
| Oxycodone-Acetaminophen | 15 | $410 | $27 |
| Minoxidil | 13 | $381 | $29 |
| Methylprednisolone | 19 | $366 | $19 |
| Lisinopril | 67 | $320 | $5 |
| Allopurinol | 66 | $288 | $4 |
| Carvedilol | 30 | $276 | $9 |
| Tramadol | 57 | $256 | $4 |
| Lactulose | 24 | $254 | $11 |
| Isosorbide Mononitrate Er | 14 | $252 | $18 |
| Gabapentin | 28 | $246 | $9 |
| Spironolactone | 19 | $185 | $10 |
| Metoprolol | 29 | $177 | $6 |
| Hydrochlorothiazide | 28 | $132 | $5 |
| Terazosin | 11 | $118 | $11 |
| Diphenoxylate-Atropine | 11 | $107 | $10 |
| Atenolol | 23 | $103 | $4 |
| Ciprofloxacin | 16 | $90 | $6 |
| Cyclobenzaprine | 11 | $81 | $7 |
| Simvastatin | 16 | $78 | $5 |
Money from drug and device companies
$33 in 2025
| 2025 | 1 | 1 | None | $33 |
| 2024 | 1 | 2 | None | $37 |
| 2023 | 3 | 8 | $2,400 | $3,919 |
| 2022 | 1 | 1 | None | $18 |
| 2020 | 1 | 2 | None | $56 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| NxStage Medical | Nxstage System One | $33 | 1 payment
|
See the published payment
| NxStage Medical | Meals · 2025-09-22 | Nxstage System One | $33 |
See earlier years (2024, 2023, 2022, 2020)
2024: $37
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $37 | 2 payments
|
2023: $3,919
| Fresenius USA Marketing | Korsuva | $3,792 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $110 | 1 payment
|
| Travere Therapeutics | None | $18 | 1 payment
|
2022: $18
| Fresenius USA Marketing | Velphoro | $18 | 1 payment
|
2020: $56
| Resmed | Airfit | $56 | 2 payments
|
Professional record
- NPI
- 1487817854
- Licence
- CA A145695, CA A145965, MS 22784California A145965: Current · expires 2026-11-30
- Group
- Telemedicine Group PC · Barton Medical Foundation · East Bay Nephrology Medical Group Inc · Siskiyou Hospital Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- MS 09481295
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 1005 Northgate Dr # 121, San Rafael, CA, 94903
- NPI first listed
- 2008-07-07
- NPI last updated
- 2022-04-20
- NPI record certified
- 2022-04-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3230 Beard Rd Ste 1, Napa, CA, 94558